| 1 | EU competition law: overview The overview provides a route-map guide to the EU competition law regime. It outlines the key legal, procedural and practical aspects likely to be encountered when confronting a competition law problem. You should read this at the start of any transaction or specific research, to give you a broad overview of the main points that are likely to arise. | Practice note: overview | Maintained |
| 2 | Hatch-Waxman Act: Overview This Practice Note provides an overview of the Hatch-Waxman Act, formally known as the Drug Price Competition and Patent Term Restoration Act of 1984, P.L. 98-417. This Note also summarizes the relevant regulatory provisions concerning branded and generic drugs, including the drug approval process, exclusivities for both branded and generic drugs, patent term extension and patent litigation under the Hatch-Waxman Act. | Practice note: overview | Maintained |
| 3 | Overview: UK competition law The Overview provides a route-map guide to the current UK competition law regime. You should read this at the start of any transaction or specific research, to give you a broad overview of the main points that are likely to arise. In March 2012 the government announced its decision on proposals to reform the UK competition regime. The government decided to establish a new single Competition and Markets Authority to replace the OFT and Competition Commission. The government also decided on various, largely procedural, changes to strengthen the mergers, markets and antitrust enforcement regimes. For further information see Government decisions on establishment of Competition and Markets Authority and reform of UK competition regime. These changes will be implemented by the Enterprise and Regulatory Reform Act 2013 (see Enterprise and Regulatory Reform Bill 2012 -13: competition tracker). | Practice note: overview | Maintained |
| 4 | Robinson-Patman Act: Overview An overview of the Robinson-Patman Act (15 U.S.C. § 13(a) –13(f)), including the elements and types of competitive harm that a plaintiff must prove to bring a claim under the Act. This Note also discusses certain potential defenses available to parties accused of violating the Robinson-Patman Act. | Practice note: overview | Maintained |
| 5 | US Antitrust Laws: Overview This Practice Note provides an overview and introduction to the main statutory provisions in the US, the US antitrust regulatory structure, the role of private antitrust enforcement and certain key concepts relevant to the application of US antitrust law. Antitrust analysis is highly fact specific and, while providing a useful starting point, the principles outlined in this Note are necessarily general in nature and do not address any of the subject matters discussed in detail. | Practice note: overview | Maintained |
| 6 | Antitrust Risks in Standard-Setting Organizations This Practice Note provides an overview of the key antitrust issues raised by participation in an SSO and licensing of standard-essential patents (SEPs). | Practice notes | Maintained |
| 7 | Competition due diligence questionnaire Examples of questions which could be raised to make enquiries about any competition law issues that may affect the target company in a corporate acquisition. See also the Practice note, Corporate transactions and merger control: practical considerations and Checklist: Competition due diligence questions. | Practice notes | Maintained |
| 8 | Competition regime: Competition disqualification orders and ... The Enterprise Act 2002 amended the Company Directors Disqualification Act 1986 to enable the Office of Fair Trading to seek disqualification orders against directors of companies that have been found to have infringed competition law. This Practice note explains the scope of these powers and their application. | Practice notes | Maintained |
| 9 | Competition regime: Transitional provisions The Competition Act 1998 entered into force on 1st March, 2000, repealing the Restrictive Trade Practices Act 1976 and Resale Prices Act 1976. This section considers the complex arrangements made by the Competition Act for the transition from the old competition regime to the new. | Practice notes | 01-Nov-2001 |
| 10 | EU enlargement and competition law This Practice note considers the impact of the European Union's enlargement on the enforcement of EU competition policy. | Practice notes | Maintained |
| 11 | Glossary This glossary contains plain-language definitions of some key legal and technical terms used in the PLC Competition materials. | Practice notes | Maintained |
| 12 | Health and Social Care Act 2012: competition and economic ... A practice note setting out the key powers and duties of Monitor to regulate competition in the healthcare market, and the applicable economic licensing regime. | Practice notes | Maintained |
| 13 | Standard-setting and competition law This Practice note examines the application of the European Commission Guidelines on the applicability of Article 101 of the Treaty on the Functioning of the European Union to horizontal co-operation agreements to standardisation and the joint-setting of standard terms. | Practice notes | Maintained |